Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesPresent and future in the treatment of diabetic kidney diseaseCannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples.Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin TreatmentCannabinoid receptor with an 'identity crisis' gets a second lookTargeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Endocannabinoid signaling at the periphery: 50 years after THC.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complicationsTargeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.Activation of cannabinoid receptor 2 inhibits experimental cystitisModulating the endocannabinoid system in human health and disease--successes and failuresRole of the endocannabinoid system in diabetes and diabetic complications.Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity.Therapeutic approaches to diabetic nephropathy--beyond the RAS.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Acute kidney injury associated with smoking synthetic cannabinoid.Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Cannabinoids and the Kidney: Effects in Health and Disease.LOX-1-Targeted Iron Oxide Nanoparticles Detect Early Diabetic Nephropathy in db/db Mice.Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions.Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina.Synthetic marijuana and acute kidney injury: an unforeseen associationIncreased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury.Cannabinoid receptors 1 and 2 are associated with bladder dysfunction in an experimental diabetic rat model.Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration.Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice.Selective cannabinoid 2 receptor stimulation reduces tubular epithelial cell damage following renal ischemia-reperfusion injury.Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression.Erzhi Formula Extracts Reverse Renal Injury in Diabetic Nephropathy Rats by Protecting the Renal Podocytes
P2860
Q24623282-75E68F64-2ACC-4B7A-97AF-B5549B58D4B3Q26864133-CF85DBCA-1A8C-4BD3-8DEE-34EA10A22A7EQ27318021-3810A65B-001A-4C8E-8E5E-216F5E0EFBB3Q27324350-79E0E844-A4D8-473A-845B-32B1F5E20557Q29397935-30415D63-A9DB-45E7-A51C-5DC416DE78B2Q33655394-5AAAFCBF-B373-41B5-AE65-C973111FCEA0Q34186015-FF503394-EB12-4C8C-A80B-B8378F58A116Q35572176-915B0D9C-03FF-4C2F-A204-1A353798053CQ35854652-BB319F6B-C165-458E-A4F2-77BFC685C48EQ35951992-47AA20FC-5221-4419-86B0-D71D33287E6EQ36346915-82C9DE4C-6937-4384-9AC6-FB3A88944FFBQ36506869-C1D9E25D-240A-4974-814D-632E16776991Q36838206-7BE914A5-A029-460B-BBF7-A4DAF86643D9Q36933683-2108E1E2-2629-4CCC-9CF2-131F98A89F6AQ37085532-A7261D9F-9077-47A6-95B3-A43BE731AD63Q37330515-F831D8D2-425D-46A0-9E1F-C81A185C4115Q37681996-6B988502-356A-4508-A3D0-91D9C6A69415Q38209811-87A06348-78A2-4B1E-9B07-052A759519A5Q38220272-03E03EC1-167C-43D7-AE80-511D57D5A086Q38236657-F1D0EEBA-392E-40B9-AADA-8E2270AA7CDEQ38255902-22E0EB0E-D67A-4259-98AA-52CBA5EF24CAQ38398867-D93B398D-71C3-49E3-BC87-5AE15C51B50FQ38468985-1DD0406A-8E4C-4E7E-A845-88AAF8C2710BQ38651395-B8058BF1-B99F-4B63-AAA1-6A44FF60FE83Q38911361-405DB0DA-94A7-4C71-A230-D9EFE6F4336BQ38924783-346BBA93-6C5D-45DD-9E98-22854436C278Q39021787-8278C147-19E4-4D01-8D6F-F36302394A5FQ39321893-B2EDB04D-839D-4C68-85F4-EFE85D521B73Q39719706-0FFBF4BF-C51D-4143-A440-330409A8D502Q41150280-70479174-A27D-4A59-A3DB-69472B81401AQ45096687-A899B747-A44A-47B9-838F-203F73846D21Q46249417-8F1E127C-5913-454A-B695-DBBF9F452A0EQ47138808-292E2A13-AAFD-46D7-AF7C-FFC364DDC0ECQ47349963-7FF8777F-32A6-4999-BFAD-EF2114C593F5Q51067641-AC3D1E0B-D029-4E0A-8E6F-F3DAA1171654Q52649284-9A57EF68-8AAB-4B01-8045-F6BC0403D081Q55415494-6819518E-5C72-4226-9E91-9858CEFC5337Q58711498-4A42D234-2A42-48A0-855C-B87CBC468E8A
P2860
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
@ast
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
@en
type
label
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
@ast
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
@en
prefLabel
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
@ast
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
@en
P2093
Federica Barutta
Gabriella Gruden
Gennaro Salvidio
Maria Pia Rastaldi
Paolo Cavallo Perin
Roberto Gambino
Silvia Pinach
P2860
P304
P356
10.2337/DB10-1809
P407
P577
2011-08-01T00:00:00Z